In vitro susceptibility of quinolone-resistant Enterobacteriaceae uropathogens to fosfomycin trometamol, in Dakar, Senegal.
We conducted a study in order to confirm the eligibility of fosfomycin trometamol as an alternative treatment to quinolones for urinary tract infections. Among 102 quinolone-resistant Enterobacteriaceae strains, resistance rates to first line-prescribed antibiotics were above 77%. The resistance rate to fosfomycin was 2%.
Nabeth
Pierre
P
Unité d'Epidémiologie, Institut Pasteur de Dakar, Dakar, Senegal. nabeth@pasteur.sn
Perrier-Gros-Claude
Jean-David
JD
Juergens-Behr
Ann
A
Dromigny
Jacques-Albert
JA
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D024881:Drug Resistance, Bacterial; D004755:Enterobacteriaceae / Q000187:drug effects*; D004756:Enterobacteriaceae Infections / Q000382:microbiology; D005260:Female; D024841:Fluoroquinolones / Q000494:pharmacology*; D005578:Fosfomycin / Q000494:pharmacology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D012675:Senegal; D014552:Urinary Tract Infections / Q000382:microbiology
D000900:Anti-Bacterial Agents; D024841:Fluoroquinolones; D005578:Fosfomycin